EssilorLuxottica Société anonyme (ESLOF)
USD 292.95
(0.06%)
USD 292.95
(0.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.63 Billion EUR | -3.49% |
| 2022 | 22.41 Billion EUR | -4.34% |
| 2021 | 23.43 Billion EUR | 20.04% |
| 2020 | 19.52 Billion EUR | 13.15% |
| 2019 | 17.25 Billion EUR | 32.62% |
| 2018 | 13 Billion EUR | 142.1% |
| 2017 | 5.37 Billion EUR | -12.05% |
| 2016 | 6.1 Billion EUR | 3.91% |
| 2015 | 5.87 Billion EUR | 6.33% |
| 2014 | 5.52 Billion EUR | 56.36% |
| 2013 | 3.53 Billion EUR | 18.4% |
| 2012 | 2.98 Billion EUR | 10.59% |
| 2011 | 2.7 Billion EUR | 24.51% |
| 2010 | 2.16 Billion EUR | 51.69% |
| 2009 | 1.42 Billion EUR | -15.95% |
| 2008 | 1.7 Billion EUR | 26.45% |
| 2007 | 1.34 Billion EUR | 10.48% |
| 2006 | 1.21 Billion EUR | -9.01% |
| 2005 | 1.33 Billion EUR | 7.55% |
| 2004 | 1.24 Billion EUR | -3.21% |
| 2003 | 1.28 Billion EUR | 36.25% |
| 2002 | 943.58 Million EUR | 0.37% |
| 2001 | 940.08 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 21.86 Billion EUR | 1.08% |
| 2024 Q2 | 21.86 Billion EUR | 0.0% |
| 2023 Q4 | 21.63 Billion EUR | 0.0% |
| 2023 Q1 | 21.86 Billion EUR | -2.47% |
| 2023 FY | 21.63 Billion EUR | -3.49% |
| 2023 Q2 | 21.86 Billion EUR | 0.0% |
| 2023 Q3 | 21.63 Billion EUR | -1.05% |
| 2022 FY | 22.41 Billion EUR | -4.34% |
| 2022 Q2 | 24.78 Billion EUR | 0.0% |
| 2022 Q3 | 22.41 Billion EUR | -9.56% |
| 2022 Q4 | 22.41 Billion EUR | 0.0% |
| 2022 Q1 | 24.78 Billion EUR | 5.77% |
| 2021 Q4 | 23.43 Billion EUR | -0.46% |
| 2021 Q3 | 23.54 Billion EUR | 21.38% |
| 2021 Q1 | 19.39 Billion EUR | -0.65% |
| 2021 FY | 23.43 Billion EUR | 20.04% |
| 2021 Q2 | 19.39 Billion EUR | 0.0% |
| 2020 Q2 | 19.68 Billion EUR | 0.0% |
| 2020 Q4 | 19.52 Billion EUR | 0.0% |
| 2020 Q1 | 19.68 Billion EUR | 14.09% |
| 2020 FY | 19.52 Billion EUR | 13.15% |
| 2020 Q3 | 19.52 Billion EUR | -0.82% |
| 2019 Q1 | 13.89 Billion EUR | 6.83% |
| 2019 FY | 17.25 Billion EUR | 32.62% |
| 2019 Q4 | 17.25 Billion EUR | 0.0% |
| 2019 Q3 | 17.25 Billion EUR | 24.14% |
| 2019 Q2 | 13.89 Billion EUR | 0.0% |
| 2018 Q4 | 13 Billion EUR | -13.25% |
| 2018 FY | 13 Billion EUR | 142.1% |
| 2018 Q2 | 5.6 Billion EUR | 0.0% |
| 2018 Q3 | 14.99 Billion EUR | 167.48% |
| 2018 Q1 | 5.6 Billion EUR | 4.34% |
| 2017 Q4 | 5.37 Billion EUR | 26.42% |
| 2017 FY | 5.37 Billion EUR | -12.05% |
| 2017 Q3 | 4.25 Billion EUR | -30.78% |
| 2017 Q2 | 6.14 Billion EUR | 0.0% |
| 2017 Q1 | 6.14 Billion EUR | 0.51% |
| 2016 Q4 | 6.1 Billion EUR | 0.0% |
| 2016 FY | 6.1 Billion EUR | 3.91% |
| 2016 Q2 | 5.87 Billion EUR | 0.0% |
| 2016 Q3 | 6.1 Billion EUR | 4.02% |
| 2016 Q1 | 5.87 Billion EUR | -0.1% |
| 2015 FY | 5.87 Billion EUR | 6.33% |
| 2015 Q1 | 5.87 Billion EUR | 6.33% |
| 2015 Q2 | 5.87 Billion EUR | 0.0% |
| 2015 Q4 | 5.87 Billion EUR | 0.0% |
| 2015 Q3 | 5.87 Billion EUR | 0.0% |
| 2014 FY | 5.52 Billion EUR | 56.36% |
| 2014 Q2 | 5.55 Billion EUR | 0.0% |
| 2014 Q3 | 5.52 Billion EUR | -0.49% |
| 2014 Q1 | 5.55 Billion EUR | 57.13% |
| 2014 Q4 | 5.52 Billion EUR | 0.0% |
| 2013 FY | 3.53 Billion EUR | 18.4% |
| 2013 Q1 | 3.14 Billion EUR | 5.23% |
| 2013 Q4 | 3.53 Billion EUR | 0.0% |
| 2013 Q2 | 3.14 Billion EUR | 0.0% |
| 2013 Q3 | 3.53 Billion EUR | 12.51% |
| 2012 FY | 2.98 Billion EUR | 10.59% |
| 2012 Q4 | 2.98 Billion EUR | -0.22% |
| 2012 Q3 | 2.99 Billion EUR | -2.72% |
| 2012 Q2 | 3.07 Billion EUR | 0.0% |
| 2011 FY | 2.7 Billion EUR | 24.51% |
| 2011 Q2 | 2.35 Billion EUR | 0.0% |
| 2011 Q4 | 2.7 Billion EUR | 0.0% |
| 2010 Q2 | 2.48 Billion EUR | 0.0% |
| 2010 FY | 2.16 Billion EUR | 51.69% |
| 2010 Q4 | 2.16 Billion EUR | 0.0% |
| 2009 Q4 | 1.42 Billion EUR | 0.0% |
| 2009 FY | 1.42 Billion EUR | -15.95% |
| 2008 FY | 1.7 Billion EUR | 26.45% |
| 2007 FY | 1.34 Billion EUR | 10.48% |
| 2006 FY | 1.21 Billion EUR | -9.01% |
| 2005 FY | 1.33 Billion EUR | 7.55% |
| 2004 FY | 1.24 Billion EUR | -3.21% |
| 2003 FY | 1.28 Billion EUR | 36.25% |
| 2002 FY | 943.58 Million EUR | 0.37% |
| 2001 FY | 940.08 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -920471.749% |
| Ansell Limited | 1.32 Billion USD | -1526.581% |
| Ansell Limited | 1.33 Billion USD | -1523.536% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -17022.356% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -2293437.128% |
| Psykey, Inc. | 2.47 Million USD | -874266.769% |
| ConvaTec Group Plc | 2.01 Billion USD | -971.875% |
| ConvaTec Group Plc | 2.02 Billion USD | -970.361% |
| Encision Inc. | 1.98 Million USD | -1090240.167% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -711366.845% |
| Innovative MedTech Inc. | 6.13 Million USD | -352508.861% |
| LifePoint, Inc. | 2.45 Million USD | -881338.89% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -212374.217% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -636135.294% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -711403.35% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -2786347.498% |
| SmileDirectClub, Inc. | 982.26 Million USD | -2102.266% |
| Sector 10, Inc. | 9.84 Million USD | -219616.197% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -1495.626% |
| SheerVision, Inc. | 1.43 Million USD | -1511144.562% |
| United Health Products, Inc. | 1.99 Million USD | -1082111.991% |
| Vasamed, Inc. | 1 Million USD | -2151695.484% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -569120.466% |
| Yubo International Biotech Limited | 2.91 Million USD | -742266.651% |